Our societal impact
Our societal impact
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.
We seek to provide solutions for some of the world’s most pressing global public health challenges and work collectively—within our walls and externally with partners—to advance better health for all.
At Johnson & Johnson, our environmental, social and governance (ESG) strategy is designed to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere.
Our Health for Humanity 2025 Goals focus our citizenship and sustainability efforts where we believe Johnson & Johnson can achieve the greatest impact.
At Johnson & Johnson, our environmental, social and governance (ESG) strategy is designed to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere.
Our Health for Humanity 2025 Goals focus our citizenship and sustainability efforts where we believe Johnson & Johnson can achieve the greatest impact.
How we create economic, environmental and social value for all those we serve
ESG and sustainability resources
Our Race to Health Equity
For nearly 20 years, both in our laboratories and on the ground in countries impacted by TB and MDR-TB, Johnson & Johnson has been supporting global efforts to end TB and combat AMR.
More from Johnson & Johnson
5 things we now know about bladder cancer
Paradigm-shifting new therapies are helping people with the disease lead longer, more comfortable lives. For Bladder Cancer Awareness Month, learn how Johnson & Johnson is helping to change the treatment landscape.
What is IL-23?
This pro-inflammatory protein is the target of potential Johnson & Johnson medications that could help treat autoimmune conditions such as psoriasis, inflammatory bowel disease and rheumatoid arthritis.
Reconnecting the meaning of these two simple words: Health&Care
Johnson & Johnson is restoring the true meaning of healthcare by developing advanced treatments and smarter and less invasive solutions for today’s most complex diseases.